cognex corp. - CGNX
CGNX
Close Chg Chg %
36.35 -0.37 -1.02%
Closed Market
35.98
-0.37 (1.02%)
Volume: 954.90K
Last Updated:
Dec 31, 2025, 4:00 PM EDT
Company Overview: cognex corp. - CGNX
CGNX Key Data
| Open $36.39 | Day Range 35.93 - 36.64 |
| 52 Week Range 22.67 - 49.76 | Market Cap $6.03B |
| Shares Outstanding 167.60M | Public Float 167.12M |
| Beta 1.52 | Rev. Per Employee N/A |
| P/E Ratio 56.17 | EPS $0.65 |
| Yield 89.36% | Dividend $0.09 |
| EX-DIVIDEND DATE Nov 13, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.83M |
CGNX Performance
| 1 Week | -1.56% | ||
| 1 Month | -6.35% | ||
| 3 Months | -22.29% | ||
| 1 Year | 0.33% | ||
| 5 Years | -55.18% |
CGNX Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
24
Full Ratings ➔
About cognex corp. - CGNX
Cognex Corp. engages in the provision of machine vision products and solutions that improve efficiency and quality in a wide range of businesses across attractive industrial end markets. It operates through the following geographical segments: the United States, Europe, Greater China, and Other. The company was founded by Robert J. Shillman, William Silver, and Marilyn Matz on January 7, 1981 and is headquartered in Natick, MA.
CGNX At a Glance
Cognex Corp.
One Vision Drive
Natick, Massachusetts 01760-2059
| Phone | 1-508-650-3000 | Revenue | 914.52M | |
| Industry | Electronic Equipment/Instruments | Net Income | 106.17M | |
| Sector | Electronic Technology | 2024 Sales Growth | 9.19% | |
| Fiscal Year-end | 12 / 2025 | Employees | 2,914 | |
| View SEC Filings |
CGNX Valuation
| P/E Current | 56.17 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 58.299 |
| Price to Sales Ratio | 6.768 |
| Price to Book Ratio | 4.028 |
| Price to Cash Flow Ratio | 41.52 |
| Enterprise Value to EBITDA | 40.703 |
| Enterprise Value to Sales | 6.576 |
| Total Debt to Enterprise Value | 0.012 |
CGNX Efficiency
| Revenue/Employee | 313,834.935 |
| Income Per Employee | 36,434.798 |
| Receivables Turnover | 6.074 |
| Total Asset Turnover | 0.456 |
CGNX Liquidity
| Current Ratio | 3.558 |
| Quick Ratio | 2.628 |
| Cash Ratio | 1.453 |
CGNX Profitability
| Gross Margin | 68.429 |
| Operating Margin | 12.582 |
| Pretax Margin | 14.378 |
| Net Margin | 11.61 |
| Return on Assets | 5.294 |
| Return on Equity | 7.026 |
| Return on Total Capital | 6.687 |
| Return on Invested Capital | 6.735 |
CGNX Capital Structure
| Total Debt to Total Equity | 4.627 |
| Total Debt to Total Capital | 4.422 |
| Total Debt to Total Assets | 3.523 |
| Long-Term Debt to Equity | 4.044 |
| Long-Term Debt to Total Capital | 3.865 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Cognex Corp. - CGNX
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.04B | 1.01B | 837.55M | 914.51M | |
Sales Growth
| +27.88% | -2.99% | -16.75% | +9.19% | |
Cost of Goods Sold (COGS) incl D&A
| 277.27M | 284.19M | 236.31M | 288.72M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 20.28M | 19.62M | 21.88M | 32.69M | |
Depreciation
| 16.62M | 16.35M | 17.27M | 21.27M | |
Amortization of Intangibles
| 3.67M | 3.27M | 4.61M | 11.42M | |
COGS Growth
| +34.32% | +2.49% | -16.85% | +22.18% | |
Gross Income
| 759.83M | 721.90M | 601.24M | 625.79M | |
Gross Income Growth
| +25.67% | -4.99% | -16.71% | +4.08% | |
Gross Profit Margin
| +73.26% | +71.75% | +71.79% | +68.43% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 444.73M | 453.24M | 478.54M | 510.73M | |
Research & Development
| 135.37M | 141.13M | 139.40M | 139.81M | |
Other SG&A
| 309.35M | 312.11M | 339.14M | 370.91M | |
SGA Growth
| +11.58% | +1.91% | +5.58% | +6.73% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| (4.26M) | 12.61M | 2.02M | (1.95M) | |
EBIT after Unusual Expense
| 319.36M | 256.05M | 120.68M | 117.01M | |
Non Operating Income/Expense
| (463.00K) | (5.36M) | 14.67M | 14.48M | |
Non-Operating Interest Income
| 6.42M | 6.90M | 16.05M | 13.98M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | - | - | - | - |
Interest Expense Growth
| - | - | - | - | - |
Gross Interest Expense
| - | - | - | - | - |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 318.90M | 250.69M | 135.35M | 131.49M | |
Pretax Income Growth
| +70.62% | -21.39% | -46.01% | -2.85% | |
Pretax Margin
| +30.75% | +24.92% | +16.16% | +14.38% | |
Income Tax
| 39.02M | 35.17M | 22.11M | 25.32M | |
Income Tax - Current - Domestic
| 33.24M | 54.04M | 32.63M | 32.53M | |
Income Tax - Current - Foreign
| 8.41M | 10.24M | 9.21M | 12.79M | |
Income Tax - Deferred - Domestic
| (20.04M) | (49.13M) | (30.61M) | (23.60M) | |
Income Tax - Deferred - Foreign
| 17.41M | 20.01M | 10.89M | 3.59M | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 279.88M | 215.53M | 113.23M | 106.17M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 279.88M | 215.53M | 113.23M | 106.17M | |
Net Income Growth
| +58.86% | -22.99% | -47.46% | -6.24% | |
Net Margin Growth
| +26.99% | +21.42% | +13.52% | +11.61% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 279.88M | 215.53M | 113.23M | 106.17M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 279.88M | 215.53M | 113.23M | 106.17M | |
EPS (Basic)
| 1.5861 | 1.2429 | 0.6574 | 0.6193 | |
EPS (Basic) Growth
| +56.17% | -21.64% | -47.11% | -5.80% | |
Basic Shares Outstanding
| 176.46M | 173.41M | 172.25M | 171.44M | |
EPS (Diluted)
| 1.5556 | 1.2325 | 0.653 | 0.6151 | |
EPS (Diluted) Growth
| +55.92% | -20.77% | -47.02% | -5.80% | |
Diluted Shares Outstanding
| 179.92M | 174.87M | 173.40M | 172.61M | |
EBITDA
| 335.38M | 288.29M | 144.58M | 147.75M | |
EBITDA Growth
| +44.23% | -14.04% | -49.85% | +2.19% | |
EBITDA Margin
| +32.34% | +28.65% | +17.26% | +16.16% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 48.65 | |
| Number of Ratings | 24 | Current Quarters Estimate | 0.192 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 1.152 | |
| Last Quarter’s Earnings | 0.22 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.963 | Next Fiscal Year Estimate | 1.385 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 13 | 13 | 20 | 16 |
| Mean Estimate | 0.19 | 0.31 | 1.15 | 1.38 |
| High Estimates | 0.22 | 0.35 | 1.48 | 1.80 |
| Low Estimate | 0.16 | 0.29 | 1.03 | 1.25 |
| Coefficient of Variance | 10.32 | 7.18 | 8.39 | 10.70 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 12 | 12 | 10 |
| OVERWEIGHT | 4 | 4 | 4 |
| HOLD | 7 | 7 | 9 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Cognex Corp. - CGNX
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Cognex Corp. - CGNX
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 26, 2025 | Carl Gerst EVP, Vision & ID Products | 4,566 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $32.73 per share | 149,445.18 |
| Feb 26, 2025 | Carl Gerst EVP, Vision & ID Products | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $33.05 per share | 0.00 |
| Feb 21, 2025 | Sheila DiPalma EVP, Employee Services | 15,134 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Matthew Moschner Senior Vice President | 25,424 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Matthew Moschner Senior Vice President | 58,260 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Matthew Moschner Senior Vice President | 68,823 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Dennis Fehr SVP, Chief Financial Officer | 25,424 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Dennis Fehr SVP, Chief Financial Officer | 68,823 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Dianne M. Parrotte Director | 8,324 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Laura A. MacDonald PFO & PAO | 12,107 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Laura A. MacDonald PFO & PAO | 33,168 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Joerg Kuechen Chief Technology Officer | 20,279 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Joerg Kuechen Chief Technology Officer | 55,141 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Tseng Chung Lee Director | 8,324 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Sheila DiPalma EVP, Employee Services | 41,460 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Robert J. Willett CEO & President; Director | 70,824 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Robert J. Willett CEO & President; Director | 193,201 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Angelos Papadimitriou Director | 8,324 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Marjorie T. Sennett Director | 8,324 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Anthony Sun Director | 8,324 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |